Literature DB >> 25643635

Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia.

Alice F Bonner1, Terry S Field, Celeste A Lemay, Kathleen M Mazor, Daniel A Andersen, Christina J Compher, Jennifer Tjia, Jerry H Gurwitz.   

Abstract

OBJECTIVES: To describe the rationales that providers and family members cite for the use of antipsychotic medications in people with dementia living in nursing homes (NHs).
DESIGN: Qualitative, descriptive study.
SETTING: Twenty-six medium-sized and large facilities in five Centers for Medicare and Medicaid Services regions. PARTICIPANTS: Individuals diagnosed with dementia who received an antipsychotic medication. MEASUREMENTS: Data were collected from medical record abstraction and interviews with prescribers, administrators, direct care providers, and family members. Textual data from medical record abstraction and responses to open-ended interview questions were analyzed using directed content analysis techniques. A coding scheme was developed, and coded reasons for antipsychotic prescribing were summarized across all sources.
RESULTS: Major categories of reasons for use of antipsychotic medications in the 204 NH residents in the study sample were behavioral (n = 171), psychiatric (n = 159), emotional states (n = 105), and cognitive diagnoses or symptoms (n = 114). The most common behavioral reasons identified were verbal (n = 91) and physical (n = 85) aggression. For the psychiatric category, psychosis (n = 95) was most frequently described. Anger (n = 93) and sadness (n = 20) were the most common emotional states cited.
CONCLUSION: The rationale for use of antipsychotic drug therapy frequently relates to a wide variety of indications for which these drugs are not approved and for which evidence of efficacy is lacking. These findings have implications for clinical practice and policy.
© 2015, Copyright the Authors Journal compilation © 2015, The American Geriatrics Society.

Entities:  

Keywords:  antipsychotic medication; dementia; nursing home

Mesh:

Substances:

Year:  2015        PMID: 25643635     DOI: 10.1111/jgs.13230

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  14 in total

1.  Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use.

Authors:  Clarissa Shaw; Kristine N Williams; Yelena Perkhounkova
Journal:  J Am Med Dir Assoc       Date:  2018-12       Impact factor: 4.669

2.  Informed Family Member Involvement to Improve the Quality of Dementia Care in Nursing Homes.

Authors:  Jennifer Tjia; Celeste A Lemay; Alice Bonner; Christina Compher; Kelli Paice; Terry Field; Kathleen Mazor; Jacob N Hunnicutt; Kate L Lapane; Jerry Gurwitz
Journal:  J Am Geriatr Soc       Date:  2016-08-22       Impact factor: 5.562

Review 3.  Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.

Authors:  Carole Parsons
Journal:  Ther Adv Drug Saf       Date:  2016-10-01

4.  Person-Centered Care Plans for Nursing Home Residents With Behavioral and Psychological Symptoms of Dementia.

Authors:  Justine S Sefcik; Caroline Madrigal; Allison R Heid; Sheila L Molony; Kimberly Van Haitsma; Irene Best; Barbara Resnick; Elizabeth Galik; Marie Boltz; Ann Kolanowski
Journal:  J Gerontol Nurs       Date:  2020-11-01       Impact factor: 1.254

5.  Testing the evidence integration triangle for implementation of interventions to manage behavioral and psychological symptoms associated with dementia: Protocol for a pragmatic trial.

Authors:  Barbara Resnick; Ann Kolanowski; Kimberly Van Haitsma; Elizabeth Galik; Marie Boltz; Jeanette Ellis; Liza Behrens; Nina M Flanagan; Karen J Eshraghi; Shijun Zhu
Journal:  Res Nurs Health       Date:  2018-02-27       Impact factor: 2.228

Review 6.  Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia.

Authors:  Jennifer Tjia; Marcus M Reidenberg; Jacob N Hunnicutt; Kelli Paice; Jennifer L Donovan; Abir Kanaan; Becky A Briesacher; Kate L Lapane
Journal:  Consult Pharm       Date:  2015-10

Review 7.  Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.

Authors:  Hannah Cioltan; Samah Alshehri; Carol Howe; Jeannie Lee; Mindy Fain; Howard Eng; Kenneth Schachter; Jane Mohler
Journal:  BMC Geriatr       Date:  2017-01-26       Impact factor: 3.921

8.  An Internet-Based Method for Extracting Nursing Home Resident Sedative Medication Data From Pharmacy Packing Systems: Descriptive Evaluation.

Authors:  Tristan Ling; Peter Gee; Juanita Westbury; Ivan Bindoff; Gregory Peterson
Journal:  J Med Internet Res       Date:  2017-08-03       Impact factor: 5.428

9.  Dementia at the End of Life and Family Partners: A Symbolic Interactionist Perspective on Communication.

Authors:  Christopher Johnson; Jordan Kelch; Roxanna Johnson
Journal:  Behav Sci (Basel)       Date:  2017-07-09

10.  Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.

Authors:  Karim Tifratene; Valeria Manera; Roxane Fabre; Auriane Gros; Susanne Thummler; Christian Pradier; Philippe Robert; Renaud David
Journal:  Alzheimers Res Ther       Date:  2017-04-26       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.